R-Pag Tablet 12.5 mg contains Eltrombopag Olamine, a thrombopoietin receptor agonist used to treat certain conditions that cause low platelet counts (thrombocytopenia). Eltrombopag stimulates the production of platelets in the bone marrow, helping patients maintain safer platelet levels and reducing the risk of bleeding complications.

R-Pag Tablet is prescribed for adults and children (as advised by a physician) with conditions such as chronic immune thrombocytopenia (ITP), thrombocytopenia due to chronic liver disease, or post-chemotherapy platelet reduction. Its oral administration provides a convenient and effective way to support platelet recovery.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

R-Pag Tablet 12.5 mg is indicated for:

• Chronic Immune Thrombocytopenia (ITP): In adults and children who have not responded adequately to standard therapies such as corticosteroids or immunoglobulins.

• Thrombocytopenia associated with chronic liver disease: To increase platelet counts before elective procedures in patients with liver disease.

• Thrombocytopenia following chemotherapy: To aid recovery of platelet levels in patients with cancer receiving myelosuppressive therapy.

This tablet is used under medical supervision to ensure safe and controlled platelet count increases.

Dosage and Administration

• The recommended starting dose is 12.5 mg once daily, taken orally at least 2 hours before or 4 hours after meals containing calcium to ensure proper absorption.

• Tablets should be swallowed whole with water and not crushed or chewed.

• Dose adjustments are made based on platelet counts and patient response, monitored regularly by a healthcare professional.

• Avoid abrupt discontinuation; therapy should continue until platelet levels stabilize or as advised by the physician.

Mechanism of Action

Eltrombopag Olamine in R-Pag Tablet is a thrombopoietin receptor agonist that:

• Stimulates thrombopoietin receptors on bone marrow megakaryocytes

• Enhances platelet production and maturation

• Helps maintain safer platelet counts, reducing the risk of bleeding in thrombocytopenic patients

By mimicking the natural action of thrombopoietin, it supports the body’s own platelet production efficiently.

Precautions

• Use only under medical supervision.

• Monitor platelet counts regularly to avoid excessive platelet levels.

• Inform the physician of allergies, liver disease, or ongoing medications.

• Avoid concurrent use with other medications that may affect platelet function unless prescribed.

• Pregnancy and breastfeeding use should only occur under physician guidance.

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Side Effects

R-Pag Tablet 12.5 mg is generally well-tolerated. Potential side effects include:

• Headache, fatigue, or dizziness

• Nausea or mild gastrointestinal discomfort

• Rarely, liver function abnormalities or thromboembolic events

• Most adverse effects are manageable with monitoring and dose adjustments

Storage

Store R-Pag Tablet 12.5 mg in a cool, dry place below 25°C, away from light and moisture. Keep out of reach of children.

R-Pag Tablet 12.5 mg is a reliable oral therapy for thrombocytopenia, helping patients maintain safer platelet levels, reduce bleeding risk, and improve overall quality of life under proper medical supervision.